Your browser is no longer supported. Please, upgrade your browser.
Crinetics Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.39 Insider Own0.20% Shs Outstand32.89M Perf Week0.00%
Market Cap499.11M Forward P/E- EPS next Y-2.36 Insider Trans8.36% Shs Float27.82M Perf Month7.32%
Income-66.70M PEG- EPS next Q-0.58 Inst Own96.00% Short Float4.97% Perf Quarter7.24%
Sales0.40M P/S1247.78 EPS this Y-86.10% Inst Trans1.03% Short Ratio9.95 Perf Half Y-3.02%
Book/sh5.69 P/B2.71 EPS next Y-0.40% ROA-39.70% Target Price- Perf Year-25.35%
Cash/sh5.76 P/C2.67 EPS next 5Y- ROE-43.40% 52W Range10.63 - 23.70 Perf YTD9.14%
Dividend- P/FCF- EPS past 5Y- ROI-46.00% 52W High-35.70% Beta-
Dividend %- Quick Ratio22.00 Sales past 5Y- Gross Margin- 52W Low43.37% ATR1.00
Employees68 Current Ratio22.00 Sales Q/Q- Oper. Margin- RSI (14)47.57 Volatility6.80% 6.70%
OptionableNo Debt/Eq0.00 EPS Q/Q6.60% Profit Margin- Rel Volume0.55 Prev Close15.40
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume139.04K Price15.24
Recom2.00 SMA20-4.43% SMA502.12% SMA2000.06% Volume39,180 Change-1.04%
Dec-23-19Initiated ROTH Capital Buy $37
Feb-14-19Initiated H.C. Wainwright Buy $35
Aug-13-18Initiated Piper Jaffray Overweight $40
Aug-13-18Initiated Leerink Partners Outperform $43
Aug-13-18Initiated JP Morgan Neutral $29
Feb-04-21 07:10AM  
Feb-03-21 07:10AM  
Jan-06-21 07:05AM  
Dec-27-20 01:37AM  
Dec-15-20 11:26PM  
Nov-23-20 07:30AM  
Nov-16-20 07:30AM  
Nov-13-20 07:30AM  
Nov-09-20 11:04AM  
Nov-06-20 08:31AM  
Oct-26-20 07:02AM  
Oct-14-20 10:25AM  
Sep-21-20 07:30AM  
Sep-04-20 07:30AM  
Sep-03-20 05:56PM  
Aug-07-20 07:30AM  
Jul-08-20 04:05PM  
Jul-05-20 05:29PM  
Jun-30-20 07:02AM  
Jun-19-20 10:05AM  
Jun-11-20 07:30AM  
May-27-20 07:30AM  
May-14-20 08:51AM  
May-08-20 09:01AM  
Apr-17-20 04:05PM  
Apr-15-20 12:22AM  
Apr-14-20 04:05PM  
Apr-07-20 07:55AM  
Apr-06-20 04:30PM  
Mar-09-20 04:10PM  
Mar-04-20 12:30PM  
Feb-19-20 07:30AM  
Jan-28-20 07:11AM  
Jan-08-20 07:30AM  
Dec-14-19 08:42PM  
Nov-26-19 04:05PM  
Nov-12-19 06:15PM  
Nov-05-19 10:31AM  
Oct-30-19 10:57AM  
Oct-28-19 11:31AM  
Sep-25-19 07:30AM  
Sep-12-19 08:40AM  
Sep-03-19 04:05PM  
Aug-13-19 06:15PM  
Jul-30-19 02:35PM  
Jul-29-19 07:30AM  
Jul-16-19 09:05AM  
May-21-19 07:30AM  
May-13-19 04:11PM  
May-07-19 12:54PM  
Mar-19-19 07:30AM  
Mar-18-19 07:30AM  
Mar-14-19 04:27PM  
Mar-13-19 04:05PM  
Feb-21-19 07:30AM  
Jan-16-19 10:16AM  
Jan-08-19 12:50PM  
Jan-02-19 04:05PM  
Nov-21-18 08:20AM  
Nov-20-18 07:30AM  
Nov-13-18 04:05PM  
Sep-26-18 04:05PM  
Aug-30-18 04:07PM  
Jul-20-18 04:05PM  
Jul-19-18 08:00AM  
Jul-18-18 11:37AM  
Jul-17-18 06:55PM  
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Struthers Richard ScottPresident & CEODec 03Buy13.104,00052,4004,000Dec 04 04:59 PM
Struthers Richard ScottPresident & CEODec 02Buy12.601,00012,6001,000Dec 04 04:59 PM
Struthers Richard ScottPresident & CEOJul 16Sale14.4617,500253,108890,805Jul 17 05:05 PM
Struthers Richard ScottPresident & CEOJul 15Sale15.3017,500267,722908,305Jul 17 05:05 PM
WIERENGA WENDALLDirectorApr 28Option Exercise0.7325,32918,49099,846Apr 29 05:01 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 17Buy14.001,071,42814,999,9923,659,381Apr 20 08:30 AM
Vivo Capital VIII, LLC10% OwnerApr 17Sale15.4084,5981,302,809298,625Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 16Sale15.2030,190458,888308,890Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 15Sale15.50215,8103,345,055312,553Apr 17 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 07Sale14.206,11586,833338,738Apr 07 07:27 PM
Vivo Capital VIII, LLC10% OwnerApr 03Sale13.80300,0004,140,000339,480Apr 07 07:27 PM
Vivo Capital VIII, LLC10% OwnerMar 09Sale19.5052810,296168,165Mar 11 05:12 PM